Form 8-K - Current report:
SEC Accession No. 0001144204-15-006906
Filing Date
2015-02-09
Accepted
2015-02-09 09:13:35
Documents
10
Period of Report
2015-02-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v400715_8k.htm 8-K 55506
2 EXHIBIT 10.45 v400715_ex10-45.htm EX-10.45 54548
3 EXHIBIT 10.46 v400715_ex10-46.htm EX-10.46 46238
4 EXHIBIT 10.47 v400715_ex10-47.htm EX-10.47 86692
5 EXHIBIT 10.48 v400715_ex10-48.htm EX-10.48 40953
6 EXHIBIT 10.49 v400715_ex10-49.htm EX-10.49 468672
7 EXHIBIT 10.50 v400715_ex10-50.htm EX-10.50 37463
8 EXHIBIT 10.51 v400715_ex10-51.htm EX-10.51 37835
9 EXHIBIT 10.52 v400715_ex10-52.htm EX-10.52 82327
10 EXHIBIT 10.53 v400715_ex10-53.htm EX-10.53 77190
  Complete submission text file 0001144204-15-006906.txt   988864
Mailing Address 632 BROADWAY SUITE 201 NEW YORK NY 10012
Business Address 632 BROADWAY SUITE 201 NEW YORK NY 10012 (212) 651-8500
TWINLAB CONSOLIDATED HOLDINGS, INC. (Filer) CIK: 0001590695 (see all company filings)

EIN.: 463951742 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-55181 | Film No.: 15586851
SIC: 2833 Medicinal Chemicals & Botanical Products